Company Filing History:
1 out of 1,361 
1 out of 282 
Years Active: 2022
Title: Laura Breda: Innovator in Hemoglobinopathy Therapy
Introduction
Laura Breda is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of gene therapy. She has developed innovative methods aimed at treating hemoglobinopathies, which are genetic disorders affecting hemoglobin in red blood cells. Her work has the potential to improve the lives of individuals suffering from these conditions.
Latest Patents
Laura Breda holds a patent for "Viral vectors for prophylaxis and therapy of hemoglobinopathies." This patent includes compositions and methods for inducing the expression of human beta-globin in erythrocytes. The method involves introducing a poly-nucleotide into CD34+ cells, which encodes essential elements for effective gene therapy. Her invention aims to provide a therapeutic approach for individuals with hemoglobinopathies, utilizing advanced genetic engineering techniques.
Career Highlights
Throughout her career, Laura has worked with esteemed institutions such as Cornell University and The Children's Hospital of Philadelphia. Her research has focused on developing innovative solutions for genetic disorders, particularly those related to hemoglobin. With her expertise, she has made significant strides in the field of gene therapy.
Collaborations
Laura has collaborated with notable colleagues, including Stefano Rivella and Alisa Dong. These partnerships have enhanced her research and contributed to the advancement of therapeutic strategies for hemoglobinopathies.
Conclusion
Laura Breda is a trailblazer in the field of gene therapy, with a focus on hemoglobinopathies. Her innovative patent and collaborations with leading researchers highlight her commitment to improving patient outcomes through scientific advancements. Her work continues to inspire future innovations in the medical field.